1-methyl-3-isobutylxanthine has been researched along with Cardiomyopathy, Congestive in 2 studies
1-Methyl-3-isobutylxanthine: A potent cyclic nucleotide phosphodiesterase inhibitor; due to this action, the compound increases cyclic AMP and cyclic GMP in tissue and thereby activates CYCLIC NUCLEOTIDE-REGULATED PROTEIN KINASES
3-isobutyl-1-methylxanthine : An oxopurine that is xanthine which is substituted at positions 1 and 3 by methyl and isobutyl groups, respectively.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Zimmermann, W | 1 |
| Scholz, H | 1 |
| Schumacher, C | 1 |
| Wenzlaff, H | 1 |
| Haverich, A | 1 |
| Näbauer, M | 1 |
| Böhm, M | 1 |
| Brown, L | 1 |
| Diet, F | 1 |
| Eichhorn, M | 1 |
| Kemkes, B | 1 |
| Pieske, B | 1 |
| Erdmann, E | 1 |
2 other studies available for 1-methyl-3-isobutylxanthine and Cardiomyopathy, Congestive
| Article | Year |
|---|---|
Effects of saterinone and its enantiomers R(+)-saterinone and S(-)-saterinone on the phosphodiesterase isoenzymes from ventricular tissue of failing human hearts and porcine hearts.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Animals; Cardiac Output, Low; Cardiomyopathy, Dilated; Cardioton | 1994 |
Positive inotropic effects in isolated ventricular myocardium from non-failing and terminally failing human hearts.
Topics: 1-Methyl-3-isobutylxanthine; Adult; Bucladesine; Calcium; Cardiomyopathy, Dilated; Cardiotonic Agent | 1988 |